Email this article Opyt primeneniya bendamustina u patsientov s retsidivom khronicheskogo limfoleykoza v rezhime monoterapii v ambulatornykh usloviyakh
- Authors: Ivashchenko AV1
-
Affiliations:
- Issue: Vol 14, No 3 (2012)
- Pages: 13-15
- Section: Articles
- URL: https://modernonco.orscience.ru/1815-1434/article/view/29493
- ID: 29493
Cite item
Full Text
Abstract
References
- Jemal A, Clegg LX, Ward E et al. Annual report to the nacional on the status of cancer 1975-2004, wild a special feature regarding survival. Cancer 2004; 101: 3-27.
- Волкова М.А. Клиническая онкогематология. М.: Медицина, 2007.
- Gridden JG. How I treat CLL up front. Blood 2010; 115: 187-97.
- Hallek M, Cheson BD, Catovski D et al. Guidelines and treatment of chronic lymphocytic leukemia: a report from the internacional Workshop Chronic Lymphocytik leukemia updating the Nacional Cancer Institute - Working Grоup 1996 quidelines. Blood 2008; 111: 5446-56.
- Donher H, Stilgenbauer S, Benner A et al. Genоmic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-6.
- Chemoterapeutic option in chronic lymphocytic leukemia: A meta-analysis of the randomized trials: CLL Trialis Collaborative Group. J Natl Cancer Inst 1999; 90: 861-8.
- Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1750-7.
- Hallek M, Fisher K, Fingerle-Rovson G et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukemia: A randomized, open-label, phase 3 trial. Lancet 2010; 376: 1164-74.
- Fischer K et al Bendamustine in combination with rituximab for patients with reapsed chronic lymphocytic leukemia: a multicentre phase II trail of German CLL Study Group. ASH Annual Meeting Abstracts 2008; 112 (11): 330.
- Rummel M, Kaizer U, Balzer C et al. Bendamustine Plus Rituximab Versus Fludarabine Rituximab in patiens with Relapsed Follicular, indolent and Mantle Cell Lymphomas - final Results of Randomized phase III Study NHL 2003; 2.
Supplementary files
